Indonesia and Russia discuss pharma technology transfers and joint manufacturing to curb drug imports

In Jakarta, BPOM head Taruna Ikrar held talks with Russian Deputy Minister of Industry and Trade Alexey Vladimirovich Gruzdev to deepen collaboration on drug manufacturing and regulatory oversight. Discussions covered expanding Indonesia's domestic supply of diabetes treatments such as insulin and GLP-1 agents, as well as advanced products like ATMPs, CAR-T therapies, monoclonal antibodies and antivirals. Building on a 2021 cooperation framework with Russia's State Institute of Drugs and Good Practices (SID&GP), the parties aim to finalise a memorandum of understanding and a roadmap toward a mutual-recognition agreement for GMP certificates.

Russian companies expressed readiness to transfer technology and establish manufacturing facilities in Indonesia, referencing the Mechnikov Institute of Biotechnology example. SID&GP offered training through the Eurasian Academy of Good Practices, including VR-based inspection modules, to strengthen Indonesia's inspection capacity. The meeting also addressed digital tools for product traceability across pharmaceutical and food supply chains, and Gruzdev invited Ikrar to visit Moscow for further discussions.